1.Newburger, JW, Takahashi, M, Gerber, MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004; 110: 2747–2771.
2.Cha, S, Yoon, M, Ahn, Y, Han, M, Yoon, KL. Risk factors for failure of initial intravenous immunoglobulin treatment in Kawasaki disease. J Korean Med Sci 2008; 23: 718–722.
3.Gamillscheg, A, Zobel, G, Karpf, EF, et al. Atypical presentation of Kawasaki disease in an infant. Pediatr Cardiol 1993; 14: 223–226.
4.Hamada, H, Terai, M, Honda, T, Kohno, Y. Marked pleural and pericardial effusion with elevated Vascular Endothelial Growth Factor production: an uncommon complication of Kawasaki disease. Pediatr Int 2005; 47: 112–114.
5.Sittiwangkul, R, Pongprot, Y. Large pleural effusion: an unusual manifestation of Kawasaki disease. Clin Pediatr (Phila) 2004; 43: 389–391.
6.Amano, S, Hazama, F, Kubagawa, H, Tasaka, K, Haebara, H, Hamashima, Y. General pathology of Kawasaki disease. On the morphological alterations corresponding to the clinical manifestations. Acta Pathol Jpn 1980; 30: 681–694.
7.Terai, M, Honda, T, Yasukawa, K, Higashi, K, Hamada, H, Kohno, Y. Prognostic impact of vascular leakage in acute Kawasaki disease. Circulation 2003; 108: 325–330.
8.Yasukawa, K, Terai, M, Shulman, ST, et al. Systemic production of vascular endothelial growth factor and fms-like tyrosine kinase-1 receptor in acute Kawasaki disease. Circulation 2002; 105: 766–769.
9.Wiesenthal, AM, Todd, JK. Toxic shock syndrome in children aged 10 years or less. Pediatrics 1984; 74: 112–117.
10.Dominguez, SR, Friedman, K, Seewald, R, Anderson, MS, Willis, L, Glode, MP. Kawasaki disease in a pediatric intensive care unit: a case–control study. Pediatrics 2008; 122: e786–e790.